首页> 美国卫生研究院文献>BMC Cancer >RGD4C peptide mediates anti-p21Ras scFv entry into tumor cells and produces an inhibitory effect on the human colon cancer cell line SW480
【2h】

RGD4C peptide mediates anti-p21Ras scFv entry into tumor cells and produces an inhibitory effect on the human colon cancer cell line SW480

机译:RGD4C肽介导抗P21RASSCFV进入肿瘤细胞并对人结肠癌细胞系SW480产生抑制作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Prokaryotic expression of recombinant proteins. (a) The sequences of the anti-p21Ras scFv, RGD4C-scFv, RGD4C-linker-scFv, and RGD4C-EGFP were separately ligated into the pET28a (+) vector to construct recombinant expression plasmids. (b) The insertion sequences were detected by polymerase chain reaction (PCR) analysis in E. coli BL21 (DE3). (*): unoptimized coding sequence. (c) SDS-PAGE analysis showed that the molecular weight of the anti-p21Ras scFv was 34 kDa, that of RGD4C-scFv was 35 kDa, that of RGD4C-linker-scFv was 36 kDa, and that of RGD4C-EGFP was 34 kDa. Codon optimization did not change the molecular weights of the expression products
机译:重组蛋白的原核表达。 (a)抗P21RASSCFV,RGD4C-SCFV,RGD4C-LINKER-SCFV和RGD4C-EGFP的序列分别连接到PET28a(+)载体中以构建重组表达质粒。 (b)通过聚合酶链反应(PCR)分析在大肠杆菌BL21(DE3)中检测插入序列。 (*):未优化的编码序列。 (c)SDS-PAGE分析表明,抗P21RAS SCFV的分子量为34kDA,RGD4C-SCFV为35kDA,RGD4C-LINKER-SCFV为36kDA,RGD4C-EGFP为34 KDA。密码子优化没有改变表达产品的分子量

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号